VALORY PAVLIK to Neuropsychological Tests
This is a "connection" page, showing publications VALORY PAVLIK has written about Neuropsychological Tests.
Connection Strength
0.824
-
Cohort Effects in Progression Rate on Cognitive and Functional Measures in an Alzheimer's Disease Clinical Cohort. J Alzheimers Dis. 2019; 71(2):659-669.
Score: 0.478
-
Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls. J Alzheimers Dis. 2013; 34(2):449-56.
Score: 0.079
-
Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord. 2009; 28(6):536-40.
Score: 0.064
-
Influence of premorbid IQ and education on progression of Alzheimer's disease. Dement Geriatr Cogn Disord. 2006; 22(4):367-77.
Score: 0.051
-
The POINTER Imaging baseline cohort: Associations between multimodal neuroimaging biomarkers, cardiovascular health, and cognition. Alzheimers Dement. 2025 Jan; 21(1):e14399.
Score: 0.045
-
Cerebello-Parietal Functional Connectivity in Amnestic Mild Cognitive Impairment. J Alzheimers Dis. 2024; 100(3):775-782.
Score: 0.042
-
Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease. J Alzheimers Dis. 2021; 80(2):735-747.
Score: 0.034
-
Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample. Dement Geriatr Cogn Disord. 2010; 30(6):486-91.
Score: 0.017
-
Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007; 24(5):375-9.
Score: 0.014